Jaineya, Myra .

HRN: 13-33-05  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
CEFTRIAXONE 1G (VIAL)
09/09/2022
09/15/2022
IV
2g
OD
Age With Severe Dehydration
Waiting Final Action 
09/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/09/2022
09/15/2022
IV
240mg
Q8
Age With Severe Dehydration
Waiting Final Action 
09/10/2022
AZITHROMYCIN 500MG TABLET (TAB)
09/10/2022
09/16/2022
PO
250mg
OD
Acute Gastroenteritis With Severe Dehydration
Waiting Final Action 
09/11/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/11/2022
09/18/2022
IV
1.2g
Q6hours
Sepsis Sec To AGE With Severe Dehydration
Waiting Final Action 
09/11/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
09/11/2022
09/17/2022
IV
80mg
OD
Sepsis Sec To AGE With Severe Dehydration
Waiting Final Action 
09/14/2022
MEBENDAZOLE 500MG (TAB)
09/14/2022
09/14/2022
PO
1 Tab
Single Dose
Ascariasis
Waiting Final Action 
09/14/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
09/14/2022
09/17/2022
PO
2ml
BID
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: